MB8-77266-57104
3 vaccinations
5 coded responses
39 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 283 / NC
- Registered
- 2020-12-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-15
Registered in v-safe
-
2020-12-15
Dose 1 — Pfizer-BioNTech
- 2020-12-15
- 2020-12-16
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-29
-
2021-01-05
Dose 2 — Pfizer-BioNTech
- 2021-01-05
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-19
- 2021-01-26
- 2021-02-04
- 2021-02-09
- 2021-02-16
- 2021-04-06
- 2021-07-06
-
2021-09-29
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling · Joint pains, Muscle or body achesFree text: Swollen/painful axillary lymph nodes in the ipsilateral side of the vaccineMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, SwellingFree text: Axillary lymph node swelling and pain, same side as vaccineMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain — Feeling: Good · Site: Pain, SwellingFree text: Axillary lymph node pain, same side as vaccineMedDRA releases: 2024-11 · check-in free text available
- 2021-10-04
- 2021-10-05
- 2021-10-08
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-12-29
-
2022-03-30
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-03-30
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-05
- 2022-04-08
-
2022-09-29
Survey response — 12 months, dose 3MedDRA: COVID-19, Pregnancy — Feeling: GoodFree text: (+) COVID June 28, recovered, doing well PregnantMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-15 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen/painful axillary lymph nodes in the ipsilateral side of the vaccine
Systemic reaction (other): Axillary lymph node swelling and pain, same side as vaccine
Systemic reaction (other): Axillary lymph node pain, same side as vaccine
Release 11 — 6 months, dose 3
Symptoms: Pregnancy
Release 12 — 12 months, dose 3
Symptoms: (+) COVID June 28, recovered, doing well Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release